ARCHIVES

Cancer Policy: Reports Lists 10 Recommendations TO Improve Quality of Care, Measurement

This article is from The Cancer Letter archive.

Vol. 25 No. 14 | April 9, 1999

Download PDF Visit The Full Archive

Related Articles

Almost Half of Faculty on IRBs Have Industry Ties, Study Finds

September 26, 2003

FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate.

May 28, 2004

In Surgery vs Radiotherapy, Outcome Differences Equalize After 15 Years Follow-up

February 22, 2013

Frelick To Receive ACCC Annual Award Will Leave NCI In July

March 6, 1987

CALG Loses Pediatrics Grant

July 20, 1979

Lineberger Endows Chair To Honor Denman Hammond.

April 13, 2001